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Abstract 
Background: Prostate cancer is the most common cancer diagnosed among adult males in the 
United States. The prognosis of prostate cancer is related to the stage, with a five year relative 
survival rate of 100% among men diagnosed with early stage prostate cancer. Modifiable risk 
factors associated with the disease include lifestyle, marital status, tobacco and alcohol history, 
physical activity, weight, diet, and geographic location. Non-modifiable risk factors include 
family history and genetic factors, race/ethnicity and nationality, age, and hormonal factors.      
Methods: A descriptive study of prostate cancer primary prevention and early detection factors 
was conducted on men living in Montgomery County, Ohio utilizing data from Ohio Cancer 
Incidence and Surveillance System, and secondary data sources. Additionally, a descriptive 
analysis was conducted on men diagnosed with prostate cancer living in Montgomery County. 
Results: Montgomery County had the third highest prostate cancer incidence and mortality 
compared to Ohio, the US, and other counties with comparable population sizes and 
demographics. Additionally, a large percentage of men were diagnosed with early stage prostate 
cancer. Eighty three percent of men living in the county diagnosed with the disease survived.    
Discussion: Men living in Montgomery County are likely to be diagnosed with early stage 
prostate cancer. The county had a low prostate cancer mortality rate which may be associated 
with factors such as early stage diagnosis. Measures can be taken to decrease prostate cancer 
health disparities through community-based participatory education, training, and research 
among racial/ethnic minorities and underserved populations in Montgomery County.  
 
 
Keywords: Prostate Cancer, Incidence, Risk Factors, Stage at Diagnosis, Symptoms, Treatment 
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Montgomery County Prostate Cancer Study 
A Descriptive Study of Prostate Cancer Incidence & Mortality in Montgomery County, Ohio, 
2000-2009 
 
Cancer is a major public health issue in the United States (US) (Centers for Disease 
Control and Prevention, 2011). It is the leading cause of global mortality, accounting for nearly 
eight million deaths in 2008, and is expected to rise to eleven and a half million deaths by the 
year 2030 (World Health Organization, 2012).  
Prostate cancer is the most common cancer, other than non-melanoma skin cancer, 
diagnosed among males of all ages, and the second leading cause of cancer-related death among 
men in the US (National Institutes of Health, 2011). The causes of prostate cancer remain 
unknown; however there are multiple known risk factors that contribute to men developing the 
disease. A risk factor is a variable associated with an increased risk of disease or infection. There 
are both modifiable and non-modifiable risk factors for prostate cancer. Modifiable risk factors 
include lifestyle, marital status, tobacco and alcohol history, physical activity, obesity, and diet. 
Non-modifiable risk factors include genetic factors, family history, race/ethnicity and nationality, 
age, and hormonal factors (U.S. National Library of Medicine, 2010). 
The purpose of this descriptive study is to examine the trend in mortality and incidence of 
prostate cancer among the male population of Montgomery County, Ohio from 2000 to 2009 
using available data sets and secondary data sources. Additionally, this study aims to address the 
various risk factors associated with prostate cancer. Lastly, a goal of this study is to describe 
some demographic related variables such as marital status, city, race, sex, age of diagnosis, and 
primary payer to determine if an association exists between these variables and prostate cancer in 
Montgomery County. This study aims to assist Public Health – Dayton & Montgomery County 
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with health promotion/preventative programs. Additionally, this study is likely to yield 
generalizable knowledge to further clinicians' understanding of prostate cancer. 
Literature Review 
Cancer, known medically as a malignant neoplasm, is a broad group of various diseases 
caused by abnormal cell proliferation. When cells in a part of the body divide uncontrollably, the 
resulting excess of tissue that develops is called a tumor or neoplasm (World Health 
Organization, 2012). Tumors may be cancerous and terminal or they may be harmless. 
Cancerous tumors are referred to as malignant tumors with the ability to spread to adjoining parts 
of the body through the lymphatic system or the blood stream; this is referred to as metastasis, 
which is the major cause of death from cancer. A harmless tumor is a neoplasm that does not 
metastasize (World Health Organization, 2012).  
Multiple factors may prompt a normal functioning cell to lose control and become 
cancerous. However, determining a single cause of cancer is difficult. There are multiple risk 
factors for cancer such as tobacco use, alcohol abuse, infections from viruses or bacteria, 
physical inactivity, poor diet, obesity, ultraviolet and ionizing radiation, and environmental 
agents such as the air we breathe, drinking water, and some foods we consume (World Health 
Organization, 2012). These risk factors can damage genes or unite with genetic abnormalities 
within cells leading to cancer (Kinzler & Vogelstein, 2002). 
Cancer can be detected through the presence of specific signs and symptoms, cancer 
screening tests, or medical imaging examinations. If a specific form of cancer is detected, it is 
diagnosed by a histopathological examination of a biopsy (Jemal et al., 2011). Most types of 
cancer are surgically removed. However, when a cancerous tumor metastasizes to multiple parts 
of the body or exists discretely in organs such as the prostate, other treatments such as 
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medication, radiation therapy, hormone therapy, chemotherapy, cryosurgery, or heat intensity 
focused ultrasound treatment of the prostate are used singly or in combination to treat the disease 
(Mayo Clinic, 2012).     
Prostate cancer was initially identified in 1853 by British surgeon James Adams, MD. 
Initially, Dr. Adams noted prostate cancer as an uncommon disease. Remarkably, almost two 
centuries later, prostate cancer has become a major public health problem (Denmeade & Isaacs, 
2002). It tends to develop slowly; however, it can develop aggressively and metastasize to other 
regions of the body such as the lymph nodes and bones. Given the slow development, many men 
typically pass away unaware that they had the disease. Early cases of prostate cancer tend to be 
asymptomatic, but some early signs may be frequent urination, difficulty initiating urination, 
blood in the urine, and weak or painful urination (American Cancer Society, 2011).  
The incidence rate of prostate cancer is significantly higher for African American men 
compared to Caucasian men; the incidence of prostate cancer in African American men is 
approximately thirty to fifty percent higher than their Caucasian counterpart of a similar age 
(Reddy, Shapiro, & Brawley, 2003). Additionally, African American men mortality rate from 
prostate cancer is two times greater than Caucasian men. The time period from diagnosis to death 
is highly dependent upon the stage and age of diagnosis, with the time period spanning longer for 
Caucasian men than African American men (Reddy, Shapiro, & Brawley, 2003). 
Greek and Italian men have lower risk in comparison to African American and Caucasian 
men; however, their risk of developing the disease tends to increase as they become acculturated 
to American style diets with a focus on saturated fats and red meat. Japanese and Chinese men 
have typically had the lowest risk of developing prostate cancer in comparison to other 
ethnicities. However, their incidence rates have been increasing within the last few years; this 
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increase has been attributed to the rising levels of obesity throughout the country (Hsing & 
Chokkalingam, 2006). 
The Prostate Gland 
The prostate gland was initially described by Niccolò Massa, a Venetian anatomist, in 
1536, and Andreas Vesalius, a Flemish anatomist, in 1538 (Denmeade & Isaacs, 2002). It is an 
exocrine gland that is part of the male reproductive system. It is a small muscular rounded organ 
about the size of a walnut. It is inferior to the urinary bladder and anterior to the rectum (Prostate 
Cancer Treatment Guide, 2010). It surrounds the upper portion of the urethra, the duct which 
expels urine from the body. The lower portion of the prostate is linked to the urinary sphincter, 
which is responsible for the control of urine flow (Prostate Cancer Foundation, 2011).  
The prostate gland is a fundamental part of the male reproductive system; however, it is 
not essential for life. It secretes a milky acidic fluid (pH of about 6.5) called prostatic fluid, 
which accounts for an estimated twenty-five percent of the volume of semen that nourishes and 
carries sperm. The fluid contains seminal-plasmin, an antibiotic which may possibly assist in the 
prevention of urinary tract infections (Prostate Cancer Foundation, 2011). Additionally, the cells 
of the prostate gland produce prostate specific antigen (PSA), a protein normally found in males 
with healthy prostates; however, higher levels are found in the presence of prostate cancer 
(American Cancer Society, 2011).  
The prostate gland is divided into two tissue types: glandular and non-glandular. 
Glandular tissue consists of glands and ducts that produce fluid and non-glandular tissue consists 
of fibromuscular tissue. The prostate gland is categorized according to a prostatic capsule that 
encloses the prostate gland and four zones: the anterior fibromuscular zone, the central zone, the 
transition zone, and the peripheral zone (Prostate Cancer Treatment Guide, 2010). 
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The anterior fibromuscular zone accounts for an estimated five percent of the prostate 
gland, but usually lacks any glandular components. The transition zone surrounds the upper 
portion of the urethra and accounts for five percent of the prostate gland. An estimated fifteen 
percent of prostate cancer cases originate in this zone (Urology Match, 2009). This zone tends to 
enlarge beyond the age of forty, which leads to difficulty urinating because of its close proximity 
to the urethra (Prostate Cancer Treatment Guide, 2010). The central zone surrounds the transition 
zone and accounts for an estimated twenty-five percent of the prostate gland (Prostate Cancer 
Treatment Guide, 2010). This zone accounts for three percent of prostate cancer cases that tend 
to metastasize to other regions of the male reproductive system. Lastly, the peripheral zone 
surrounds the lower portion of the urethra and makes up seventy percent of the prostate gland in 
young men. This zone is the primary site of about seventy to eighty percent of prostate cancer 
(Urology Match, 2009).    
Etiology of Prostate Cancer 
Prostate cancer is the most common cancer among men in the western hemisphere and 
the second leading cause of death among men in the US (Hsing & Chokkalingam, 2006). Many 
studies have shown that approximately eighty percent of men eighty years and older were 
unaware they had the cancer prior to passing away. Thirty percent of men in their fifties and 
eighty percent of men in their eighties from various geographic areas who passed away from 
various causes of death were found to have prostate cancer during autopsy (American Cancer 
Society, 2011).  
The antecedent to prostate cancer is known as prostatic intraepithelial neoplasia (PIN) 
which is defined as alterations involving the glands and ducts of the prostate. There are three 
grades of PIN. Low grade PIN entails abnormal growth with abnormal cell replication, 
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dissimilarity in size and shape of the nucleus, and asymmetrical cell spacing. High grades refers 
to PIN grades 2 and 3, which entails moderate to severe cell replication, and irregular cell 
spacing. Individuals found to have high grade PIN are at a significantly greater risk of 
developing prostate cancer (Wang et al., 2011).     
Prostate cancer develops within the gland cells of the prostate. The gland cells play a part 
in developing the prostatic fluid found in semen. The cancer normally starts with small changes 
in the shape and size of the prostate gland cells (American Cancer Society, 2011). Despite the 
changes that occur in the gland cells of the prostate, there are multiple types of prostatic 
carcinomas that affect the different zones of the prostate. These types of prostatic carcinomas 
include: prostatic adenocarcinoma, small cell carcinoma, squamous cell carcinoma, and 
transitional cell carcinoma (Wagner, Huang, & Cheng, 2012).  
Prostatic adenocarcinoma tends to arise in the peripheral zone, the main glandular zone of 
the prostate, and is the most common type of prostate cancer diagnosed. It accounts for an 
estimated eighty to ninety percent of prostate cancer cases. Adenocarcinoma refers to a 
cancerous growth that begins in epithelial cells with glandular properties. Epithelial cells play a 
role in protecting or enclosing organs and removing foreign substances; some produce mucus 
and other secretions. Prostatic adenocarcinoma refers to a malignant growth that originates in the 
glandular tissue of the prostate gland (Prostate Cancer Treatment Guide, 2010).  
Small cell carcinoma (SCCA) is an uncommon type of prostate cancer that also originates 
in the peripheral zone and accounts for less than one percent of prostate carcinomas (Furtado, 
Lima, Nogueira, Franco, & Tavora, 2011). Some cases of SCCA of the prostate are mixed with 
prostatic adenocarcinoma (Wagner, Huang, & Cheng, 2012). This type of prostate cancer is very 
aggressive and difficult to detect because it does not lead to an enhanced level of PSA. As a 
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result this type of cancer tends to be detected when it has reached an advanced level (Epstein, 
2008).  Squamous cell carcinoma (SCC) of the prostate is a non-glandular cancer that affects the 
anterior fibromuscular zone of the prostate. It accounts for approximately one percent of all 
prostate carcinomas. Similar to SCCA, this form of prostate cancer is difficult to detect because 
PSA levels do not increase when the cancer is present (Malik et al., 2011).  
Lastly, prostatic transitional cell carcinoma (TCC) is an extremely rare form of prostate 
cancer that is involved in the urethral region of the prostate and accounts for less than one 
percent of prostate cancer cases. Primary prostatic TCC involves the entire region of the prostatic 
urethra, while secondary prostatic TCC involves the neck of the bladder or the tissues of the 
posterior portion of the prostate (Shen & Cheng, 2012). 
While there are various types of prostatic carcinomas, their etiology remains ambiguous 
(Wang et al., 2011). However, the vast majority of cases are related to prostatic adenocarcinoma, 
which is the most wide spread form of the disease (Prostate Cancer Treatment Guide, 2010).  
Despite the ambiguous etiology of prostate cancer, there are both modifiable and non-
modifiable risk factors associated with the development of the disease. Understanding of these 
risk factors can enhance the knowledge of the disease and increase the survival rate by diagnosis, 
in turn reducing the current mortality and incidence trends of the disease.   
Modifiable Risk Factors 
Lifestyle 
Diets high in fats are linked to increased risk of prostate cancer due to increased 
production of androgens and estrogen throughout the body (Hsing & Chokkalingam, 2006). 
Consumption of red meat and processed meat has been consistently linked to prostate cancer. 
Dietary calcium from dairy or supplemental products has also been linked to prostate cancer. 
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Due to the role calcium has in the regulation of the synthesis of vitamin D, it may potentially 
down regulate the anti-proliferative effect vitamin D has on prostate cancer (Hsing & 
Chokkalingam, 2006).  
Obesity has been more consistently linked with the development of prostate tumors and 
abdominal obesity may be related to the development of prostate cancer. Although the role 
obesity has on prostate cancer is unclear it is linked to many risk factors of prostate cancer. This 
includes the high consumption of meat and fatty foods, hormone metabolism, as well as insulin 
metabolism. The obesity prevalence throughout the US population is strongly correlated with the 
risk of developing prostate cancer (Freedland, 2005). Lastly, research has shown that married 
males have a higher survival rate from prostate cancer than unmarried men (Abdollah et al., 
2011).    
Marital Status 
There is a positive association between married men and prostate cancer survival rate 
(Abdollah et al., 2011). In a North American population based cohort study, it was found that 
married men with prostate cancer had a significantly higher survival rate compared to divorced, 
separated, or widowed men.  Several prostate cancer investigations have shown that married men 
have a lower mortality rate than their unmarried counterparts. In a study of 30,000 married and 
single men, there was a negative survival trend for single men diagnosed with prostate cancer 
compared to their counterparts. Additionally, other studies have shown marriage to be a positive 
predictor of men seeking treatment compared to single or widowed men (Abdollah et al., 2011).  
In a recent study, 163,697 benign prostate cancer patients were treated with radical 
prostatectomy. Cox regression analysis, a statistical method used for investigating the association 
between the survival of a patient and multiple variables, was used to determine if there was a 
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relationship between marital status and prostate cancer. The finding demonstrated that single, 
divorced, and/or widowed men were more likely to have the aggressive form of prostate cancer 
at radical prostatectomy compared to married men (Abdollah et al., 2011).    
Additionally, research studies have shown that single, widowed, and divorced men were 
more likely to abuse tobacco and alcohol (Abdollah et al., 2011). Men under the age of sixty five 
who smoke a daily pack of cigarettes increase their risk of developing an aggressive type of 
prostate cancer compared to nonsmokers (Stein & Colditz, 2004). 
Tobacco History 
A history of tobacco use is a major cause of preventable deaths globally, accounting for 
an estimated five million deaths annually. In the US, adult smokers lose an estimated thirteen 
years of potential life due to the negative effects associated with smoking. Additionally, it is 
estimated that fifty percent of all smokers pass away from tobacco-related diseases (Stein & 
Colditz, 2004). Tobacco use contributes to approximately thirty percent of all forms of cancer in 
the US. Increasing evidence suggests that smoking is related to an elevated risk of prostate 
cancer; however the link between cigarette smoking and prostate cancer has not been supported 
by most observational studies. There are multiple ways in which cigarette smoking might 
adversely promote the development and progression of prostate cancer (Watters, Park, Hollen, 
Schatzkin, & Albanes, 2009). However, the risk of developing prostate cancer from tobacco use 
is not limited to cigarette smoking; the risk increases with smokeless tobacco, cigar use, and pipe 
smoking (Stein & Colditz, 2004).   
Tobacco use negatively influences some sex hormones such that men who smoke have 
elevated levels of testosterone and lower levels of estradiol, which can lead to a more aggressive, 
hormone sensitive cancer consequently increasing prostate cancer mortality. Additionally, 
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smokers are also exposed to a wide variety of carcinogens such as cadmium, which can 
negatively affect prostate tumor growth (Watters et al., 2009). The proliferative and carcinogenic 
effects cadmium has on prostate cancer have been illustrated in vitro and in vivo. In a 2002 
study, evidence supporting the effects of cadmium on prostate cancer were demonstrated when 
human prostate cancer cells were exposed to cadmium. The results were a 2.4 fold increase in 
cell division within one week and a 2.7 fold increase within two weeks (Martin et al., 2002).  
Lastly, a study conducted on smokers and drinking behavior found that social smoking 
increased the risk of alcohol abuse. Social smokers were less likely to drink daily than smokers; 
however they were more likely to exceed the daily and weekly drinking quantity suggested by 
the National Institute on Alcohol Abuse and Alcoholism (NIAAA) (Harrison, Desai, & McKee, 
2008).   
Alcohol History 
A history of alcohol abuse is responsible for about two million deaths annually. Alcohol 
is a carcinogen that may perhaps increase cancer risk by operating as a solvent thus allowing 
carcinogens to infiltrate the mucus secreting membrane lining of the body cavity, or as an irritant 
resulting in increased cell death, or perhaps as a transporter carrying carcinogens to the basal 
layer of the membrane lining the body cavity (Stein & Colditz, 2004). Men who consume 
alcohol heavily on a normal basis are likely putting themselves at risk for developing prostate 
cancer.  
A study conducted at the University of California on the association between alcohol 
abuse and the risk of developing prostate cancer found that men who drank heavily diminished 
the possible preventive properties of finasteride, a drug used to reduce the risk of prostate cancer 
in some men. The study focused on the alcohol drinking and consumption patterns of 10,920 
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males, who were enrolled in the Prostate Cancer Prevention Trial (PCPT). The PCPT is a 
National Cancer Institute study examining the possible benefits of finasteride. The findings from 
the study suggested those men who drank at least fifty grams or more of alcohol daily increased 
their risk of developing an aggressive form of prostate cancer. Men who drank heavily on a daily 
basis were at a significantly higher risk of developing high-grade prostate cancer (Gong et al., 
2009). Another study researching the relationship between alcohol intake, body fat, and physical 
activity found that alcoholics are less physically active than non alcoholics (Liangpunsakul, 
Crabb, & Qi, 2010).      
Physical Activity 
Throughout the US adults in general do not get the recommended level of physical 
activity needed to maintain a healthy lifestyle. The recommended level of physical activity is 150 
minutes of weekly moderate intensity activity (Centers for Disease Control and Prevention, 
2010). Physical activity is a preventative measure against the development of various chronic 
diseases (Touvier et al., 2010). There is a positive relationship between the prevention of chronic 
diseases and physical activity. There is strong evidence that daily physical activity contributes to 
both primary and secondary prevention of numerous chronic diseases and is related to a lower 
risk of early death (Darren, Warburton, Nicol, & Shannon, 2006). 
According to the Behavioral Risk Factor Surveillance System (BRFSS) data from 2008, 
only 64.5% of adults age 18 to 65 met the recommended levels of physical activity. Twenty-
seven percent of adult males were more likely to meet the recommended levels of physical 
activity compared to 25.5% of women. Among ethnic groups, 56.5% of African American adults 
and 50% of Hispanics were likely to meet the recommended levels of physical activity, while 
72.1% of Caucasian Americans met the recommended levels (Brownson, Boehmer, & Luke, 
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2005). Globally, physical inactivity causes an estimated two million deaths annually (Stein & 
Colditz, 2004). Additionally, lack of physical activity may be associated with the risk of 
developing prostate cancer, especially in African American men (Moore et al., 2009).   
Research studies are inconsistent concerning the effects physical activity has on prostate 
cancer. While it is feasible that physically active men experience a lower risk of prostate cancer, 
the organic mechanisms that explain this relationship are not clear, but may be related to 
alterations in energy balance, hormones, immunity, insulin-like growth factors (IGFs), and 
antioxidant defense mechanisms (National Institutes of Health, 2009b). In a prospective study of 
physical activity and prostate cancer, it was suggested that regular vigorous activity could slow 
the development of prostate cancer in men age sixty-five and older (Giovannucci, Leitzmann, 
Stampfer, & Willett, 2005).  
Particularly among African American men, the association between physical activity and 
prostate cancer has not been thoroughly examined. A cohort study conducted examining the 
intensity of physical activity among African American and Caucasian men during different age 
periods in relation to prostate cancer incidence found that physical activity may reduce prostate 
cancer specifically in African Americans. The study included a total of 160,006 Caucasian men 
and 3,671 African American men age fifty-one to seventy-two. During a seven year period 9,624 
Caucasian men and 371 African American men developed prostate cancer. Among Caucasian 
men there was no association between physical activity and prostate cancer. However, African 
American men engaging in at least four hours of physical activity related to a thirty five percent 
lower risk of developing the disease (Moore et al., 2009).  
Physical inactivity in the last few years has increased because of a shift from a more 
laborious to deskbound occupations. In the last few decades, there has been on average a weight 
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increase in American men of twelve pounds. Lack of physical activity is one of the major factors 
leading to a rising rate of obesity (Cutler, Glaeser, & Shapiro, 2004). In a 2005 study, a positive 
association between body weight and developing prostate cancer was found in men with higher 
body mass index or men who were obese.  
Obesity 
“Obesity is the excessive accumulation of body fat that causes undesirable effects on 
health and reduces life expectancy” (Blair, 2008). The increase in obesity prevalence in the last 
two decades is likely caused by the alterations in diet and physical inactivity (Freedland, 2005). 
Obesity has been linked to the more aggressive form of prostate cancer. However, the specific 
reason for this association is complex. Multiple organic rationalizations have been presented 
including physical inactivity, poor diet, and changes in serum hormone concentration, such as 
testosterone, estrogen, and insulin (Freedland, 2005).  
Obesity has been linked with the decrease in free testosterone levels. Testosterone is 
responsible for the development of male secondary sex characteristics. Furthermore, testosterone 
is a key component in prostate growth. Data from retrospective studies have proposed that 
testosterone exerts a differentiated effect on prostate cancer and that lower levels of testosterone 
found in obese men is related to the aggressive form of prostate cancer (Freedland, 2005). A 
prospective cohort study conducted at Johns Hopkins Bloomberg School of Public Health found 
that obese men with lower levels of testosterone were at higher risk of developing prostate 
cancer (Platz et al., 2005). Lower levels of free testosterone found in obese men predisposes 
them to advanced prostate cancer, which may potential elucidate the higher mortality among 
obese men from prostate cancer (Freedland, 2005).    
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Multiple prospective cohort studies have confirmed that obese men have a higher risk of 
developing and dying from prostate cancer. A prospective cohort study conducted by the 
American Cancer Society found that a higher body mass index (BMI) was positively associated 
with the risk of death from prostate cancer (Calle, Rodriguez, Thurmond-Walker, & Thun, 
2003). BMI is a method used to measure a person’s weight in relation to their height and verifies 
if a person is underweight, overweight, or obese. A BMI within the range of 19–24.9 is 
considered normal weight, while a BMI within the range of 25–29.9 is considered overweight, 
over 30–34.9 is considered obese, and 35–40 is considered morbidly obese (Wilder, 2009). The 
prospective cohort study included 900,000 adult males who were cancer free in 1982. The men 
were followed for sixteen years to evaluate their mortality risk from prostate cancer. It was found 
that men with a BMI between 30 and 34.9 were twenty percent more likely to pass away from 
prostate cancer than men with a normal weight and morbidly obese men were thirty five percent 
more likely to die from prostate cancer (Calle et al., 2003).  
A theory for the higher mortality rate among obese men suggests that the size of the 
prostate in obese men is larger compared to normal weight men. Thus making it difficult to feel a 
tumor and harder to find the cancer prior to a biopsy. Additionally, obese men have lower PSA 
concentrations due to lower levels of testosterone. Due to the lower levels of testosterone, during 
a PSA examination, obese men are less likely to have abnormal PSA results, leading to fewer 
prostate cancers detected in the early stage of the disease (Freedland, 2005).  
Reducing the risk of developing prostate cancer due to obesity can be accomplished 
through dietary improvements, thus creating a balance between caloric intake and physical 
activity (Stein & Colditz, 2004).  
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Dietary Improvements 
Studies in recent years have focused on the relationship between diet and prostate cancer. 
Multiple factors have been investigated from diets rich in fruits and vegetables to diets rich in red 
meat and animal fats. Eating a healthy well balanced diet rich in fruits and vegetables may 
reduce the risk of developing prostate cancer (Stein & Colditz, 2004).   
Diets high in sugar increase the risk of developing prostate cancer. A surplus of sugar is 
stored as fat in the body, which leads to increased body fat increasing the production of 
testosterone (Prostate Cancer Treatment Guide, 2010). Diets that rely on red meat as a source of 
protein, rich in animal fats, or contain high levels of simple sugars, are positively correlated with 
prostate cancer. Foods such as berries, green tea, red wine, and pomegranates can have protective 
or preventative effects against prostate cancer. These types of foods contain anti-oxidants which 
can shield prostate cells from the detrimental consequences of oxidation. Additionally, altering 
sources of protein from red meat to fish, soy, or beans is a preventive factor that reduces the 
chances of developing prostate cancer. Vegetables, such as carrots and broccoli, and fresh fruit 
such as tomatoes, have lycopene, beta carotene, and variety of vitamins and minerals which may 
also play a role in preventing prostate cancer (Prostate Cancer Treatment Guide, 2010).  
Adequate amounts of selenium have also been found to reduce the risk of prostate cancer 
(Prostate Cancer Treatment Guide, 2010). Studies conducted on animals suggest that higher 
intake of selenium reduces the risk of prostate cancer. Selenium offers protection against prostate 
cancer because it is a significant part of antioxidant enzymes and an important element in 
immune system function (Stein & Colditz, 2004).  
Men from Japan, Italy, and Greece who maintain a diet rich in fresh fruits, vegetables, 
fish, rice, green tea and olive oil have a lower incidence rate of prostate cancer. However as these 
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men migrate to the US and become acculturated, they tend to change their dietary habits, 
consuming larger amounts of western food, thus increasing their risk of developing prostate 
cancer (Prostate Cancer Treatment Guide, 2010). Lastly, geographic locations have been linked 
with a lower risk of developing prostate cancer. Research has shown that the lower rate of 
prostate cancer in some geographic regions such as Japan has less to do with lifestyle, and more 
to do with customary diets and geographic location. 
Geographic Location 
The US, Canada, Australia, and most Western European countries have the highest 
prevalence, incidence, and mortality rates of prostate cancer globally. Conversely, Japan, Italy, 
and Greece have the lowest rates of developing and dying from the disease. The highest 
mortality rates of prostate cancer are found in countries with the high latitudes and low levels of 
ultraviolet (UV) light such as Canada and Sweden (Prostate Cancer Treatment Guide, 2010).  
Multiple studies have attributed the risk of prostate cancer on UV light in addition to 
dietary habits (Prostate Cancer Treatment Guide, 2010). Insufficient exposure to UV light may 
increase the mortality rate of prostate cancer. UV light stimulates the production of vitamin D, 
which reduces the risk of prostate cancer development. There is considerable evidence, in vitro 
and in vivo, for the anticancer effects of UV light on prostate cancer. Multiple case control 
studies conducted in prostate cancer have shown that adequate exposure to UV light and levels 
of vitamin D are related to a decreased level of prostate cancer risk (Moon, Fryer, & Strange, 
2005).    
African American men have the highest incidence and mortality rate of prostate cancer in 
the world (Reddy, Shapiro, & Brawley, 2003). The reason for this high rate is unclear although it 
is believed that it may be due to African American men not receiving adequate UV light due to 
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their increased levels of skin melanin, which blocks some UV exposure (Prostate Cancer 
Treatment Guide, 2010). Despite the changes men can make to reduce their chances of 
developing prostate cancer prevention, non-modifiable risk factors are unchangeable.  
Non-Modifiable Risk Factors 
Family History & Genetic Factors 
Data from a twin study propose that approximately 42% of the risk of developing prostate 
cancer may be attributed to genetic factors (Hsing & Chokkalingam, 2006). Research shows that 
a family history of prostate cancer increases a male's chance of developing the disease by twenty 
to thirty percent, principally if the family member is a brother, father, or son (Stanford & 
Ostrander, 2001). The genetic factors related to prostate cancer includes BRAC 1 & 2 genes, 
hereditary prostate cancer X (HPCX), and the perlecan gene.   
BRAC 1 & 2 genes are thought to be related to predisposing a person to developing 
prostate cancer. They are classes of genes known as tumor suppressors. Under normal conditions 
the genes function to thwart the genetic alteration of cells that induce the inception of cancer by 
slowing or stopping the proliferation of cells when the DNA of cells become damaged, which 
gives the cells the opportunity to repair errors in DNA before they continue to proliferate leading 
to cancer. The risk of developing prostate cancer increases with the mutation of either of these 
genes. An alteration specifically in the BRAC 1 gene enhances the risk of developing prostate 
cancer in males over sixty five years old. Alternatively, younger men under sixty five risk 
increases with mutations in the BRAC 2 gene (National Institutes of Health, 2009b).  
The perlecan gene is also thought to play a part in the onset of prostate cancer. It is 
localized on a region of DNA that is normally mutated in prostate cancer patients. Depending on 
the needs of the body, the proteins function in signaling cell proliferation can be turned off and 
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on. However, at the onset of prostate cancer, the cells consistently receive proliferation signals, 
which in turn promote the advancement of prostate cancer (Datta et al., 2006). Since the 
development of prostate cancer appears to the result of multiple complex interactions ranging 
from lifestyle to genetics, family history is an appropriate genomic tool that captures these 
interactions (Ahn et al., 2008). 
Family history is a fundamental public health instrument for the identification of 
individuals who are at high risk for developing a particular disease, such as prostate cancer. It 
can be essential to individualized cancer prevention strategies (Ahn et al., 2008). A family 
history of prostate cancer was initially defined as prostate cancer meeting three criteria: prostate 
cancer within three consecutive generations, two relatives diagnosed with the disease before the 
age of fifty five, or three or more family members diagnosed with the disease. However, it was 
later suggested that this criteria would exclude families with autosomal recessive or X-linked 
transmission of the disease (Delongchamps, Singh, & Hass, 2006).  
Multiple studies have consistently shown that a family history of prostate cancer increases 
the risk of developing the disease (Hsing & Chokkalingam, 2006). The hereditary form of 
prostate cancer comprises an estimated five to six percent of reported cases. Thirty-three percent 
of prostate cancer cases diagnosed before age sixty are hereditary. Evidence has shown that 
prostate cancer is genetically heterogeneous. Several genes located on the human prostate cancer 
1 chromosome have been linked to hereditary prostate cancer carcinogenesis (Delongchamps, 
Singh, & Hass, 2006).      
Men who have a first-degree male relatively with a history of prostate cancer are two to 
three time more likely to develop the disease (Hsing & Chokkalingam, 2006). A first-degree 
relative is a family member such as a father, sibling, or child. In a ten year prospective cohort 
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study, it was found that men with a positive family history of prostate cancer were over four 
times more likely to have the aggressive form of the disease when diagnosed. Some studies have 
found that the risk of developing prostate cancer is three times greater for men with siblings who 
have a history of prostate cancer than their parental history (Ahn et al., 2008). Additionally, 
African American men with a family history of prostate cancer have twice the risk of developing 
the disease than Euro-American men (Bloom, Stewart, & Oakley-Girvans, 2006).   
Race/Ethnicity/Nationality 
In the US, prostate cancer is sixty-six percent more likely to develop in African American 
men compared to men of different races. Chinese and Japanese men tend to have some of the 
lowest rates of prostate cancer when compared to African American and Caucasian men (Hsing 
& Chokkalingam, 2006). African American men are twice as likely to die from the disease 
compared to Caucasian men. In contrast, black men living in Africa have a lower rate of prostate 
cancer when compared to black men globally. A cohort study comparing the outcomes of 396 
Caucasian American and 524 African American for ten years found that the mortality rate for 
prostate cancer was higher in African American men, especially in those under the age of 
seventy. This higher incidence and mortality rate of prostate cancer in African Americans has 
been linked to a lower literacy rate, genetics, diets high in saturated fat, and lack of access to 
medical care (Hsing & Chokkalingam, 2006).  
African Americans with prostate cancer are unlikely to seek treatment. Studies have 
shown that similar treatments among different racial groups yield similar results. For instance, 
African American men who have equal access to health care compared to Caucasian men and a 
higher literacy rate tend to have a comparable incidence and mortality to Caucasian men (Reddy, 
Shapiro, & Brawley, 2003).  
MONTGOMERY COUNTY PROSTATE CANCER                                                               25 
Compared to Caucasians, the proportion of African Americans with an aggressive form 
of prostate cancer is significantly higher. Multiple studies show that there is only a small 
difference in prostate cancer survival among African American men and Caucasian men who are 
comparably treated (Reddy, Shapiro, & Brawley, 2003). Ethnicity is a consistently observed but 
less understood risk factor of prostate cancer (Hsing & Chokkalingam, 2006). Lastly, all men 
regardless of their race are at greater risk of developing the disease beyond the age of fifty 
(Delongchamps, Singh, & Hass, 2006).  
Age 
Prostate cancer is known as the cancer of middle age and older men. Age is a strong risk 
factor for prostate cancer; men under the age of fifty are rarely diagnosed with the disease. 
However, beyond this age prostate cancer incidence increases exponentially (Delongchamps, 
Singh, & Hass, 2006). The specific role age plays in the development of the disease is unclear. 
However, research has provided evidence that prostate cancer arises from age related changes in 
the glandular epithelium of the prostate. Caucasian American men, aged 75 to 79, have 
approximately one hundred and thirty times the risk of developing the disease compared to 
Caucasian American men aged 45 to 49; several studies examining the genetic changes in 
prostate cancer tissue, suggest that damage to DNA with age may to some extent explain this 
trend. A study conducted on the age-related changes in 795 deceased African American men 
from Washington DC, did not find a relationship between tissue changes related to aging and the 
presence of prostate cancer (Delongchamps, Singh, & Hass, 2006). Many changes take place in a 
male's body as aging occurs. Several of these alterations are due to the level of circulating 
hormones throughout the body which increases their risk for developing prostate cancer. 
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Hormonal Factors 
The growth and preservation of the prostate depends on testosterone and the conversion 
of dihydrotestosterone. However, the specific role hormones play in the etiology of prostate 
cancer is unclear. In laboratory studies, it was found that the administration of testosterone to rats 
induces prostate cancer and encourages cell growth and hampers prostate cell death. Additional 
studies suggest that high levels of testosterone and dihydrotestosterone, and low levels of 
estrogen may potentially elevate the risk of developing prostate cancer (Hsing & Chokkalingam, 
2006).  
IGFs have also been linked to prostate cancer. IGFs originate within the liver and consist 
of two hormones, IGF-1 and IGF-2, which play an important role in cellular growth and 
metabolism. Two case control studies conducted, found a strong association between the levels 
of IGFs circulating in the body and the risk of developing prostate cancer. The results from these 
studies were also substantiated in a Physician Health Study, in which a direct relationship was 
found between the development of prostate cancer and IGF-1 levels. Males in the top twenty-five 
percent of IGFs circulating throughout their bloodstream had greater than four times the risk of 
developing prostate cancer compared to males in the bottom twenty-five percent. To date IGF's 
are identified as the strongest risk factor for prostate cancer (Hsing & Chokkalingam, 2006). 
In a meta-analysis of fourteen case control studies, a forty-seven percent increase in the 
risk of developing prostate cancer was reported with an elevated level of IGF-1 (Wiggle, Turner, 
Gomes, & Parent, 2008). In addition six meta-analysis studies reported a forty-nine percent 
increase in the risk of developing prostate cancer in men with elevated levels of IGF-1 (Renehan 
et al., 2006). In a case control study, a dose response relationship was found between prostate 
cancer and IGF-1 levels. This relationship between prostate cancer and IGF-1 appeared to be 
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stronger for men under the age of fifty-nine and for men with advance cases of prostate cancer 
(Stattin et al., 2004).  
Lastly, vitamin D is a steroid hormone obtained primarily from sunlight exposure. It is a 
preventative hormone that protects the cells of the prostate from over production and death. 
Additionally, vitamin D has been found to hinder prostate growth in a living organism (Hsing & 
Chokkalingam, 2006).   
Despite the modifiable and non-modifiable risk factors associated with the disease, the 
symptoms associated with the cancer and treatments used are similar.   
Symptoms & Treatment of Prostate Cancer  
The majority of men with prostate cancer do not have accompanying symptoms. Many 
prostate cancer cases are normally discovered during a prostate biopsy, which is performed after 
a serum PSA blood test is done, or by a digital rectal examination. These examinations are part 
of the screening process for prostate cancer. The symptoms of prostate cancer normally include 
difficulty urinating, increased urination accompanied by pain, and/or urinary retention. Some 
men may feel a sense of bladder fullness after urination because their bladder has not been fully 
emptied. A few less common symptoms in the early stages of prostate cancer include painful 
ejaculation, or impotence. These symptoms alone do not suggest or confirm the presence of 
prostate cancer. Many of these symptoms can occur in men with a benign enlargement of the 
prostate (National Institutes of Health, 2009a). 
Treatment for the disease depends on multiple factors such as a person's age, current 
medical conditions, and the scope of the tumor; for example, the risk of older men with chronic 
conditions having surgery to treat the disease greatly outweighs the benefit. There are six 
standard types of treatment used for patients with prostate cancer which includes: watchful 
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waiting, surgery, radiation therapy, hormone therapy, chemotherapy, and biologic therapy 
(National Institutes of Health, 2009a).  
Watchful waiting is normally used on older patients with medical conditions and who are 
in the early development of the disease. It entails withholding treatment and observing the 
progress of a patient's condition to assess whether the symptoms change for the better or worse. 
Surgery as an option for prostate cancer treatment is normally offered to patients in overall good 
health. The types of surgery offered includes: pelvic lymphadenectomy, which entails the 
removal of the lymph nodes in the pelvis to asses if they are cancerous and radical 
prostatectomy, which entails removal of the prostate, surrounding tissue and seminal vesicles. 
Additional treatments include radiation therapy to kill cancerous cells; hormone therapy, which 
removes hormones or prevents their action while slowing or stopping the growth of cancerous 
cells; chemotherapy, which uses medication to impede the development of cancerous cells; and 
biologic therapy, which utilizes the patient's immune system to battle the disease by the use of 
substances developed by the body or synthetic substances to directly boost, or restore the body's 
innate defense against the disease (National Institutes of Health, 2009a). Another type of 
treatment includes brachytherapy, which is a treatment using a radioactive source situated inside 
or close to the cancerous tissue (Sadetsky, Elkin, Latini, DuChene, & Carroll, 2008). 
Knowledge of the modifiable and non-modifiable risk factors, symptoms, and treatment 
of prostate cancer can assist in the development of strategies to increase the survival rate by the 
stage of diagnosis. 
Prostate Cancer Survival by Stage at Diagnosis 
The stage of prostate cancer at diagnosis is a vital determinant of the relative survival 
among those with the disease (Hamilton & Ries, 2007). Prognosis of prostate cancer is strongly 
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related to the stage, with a five year relative survival rate of 100% among men diagnosed with 
localized (confined to primary site) or regional (spread to regional lymph nodes) prostate cancer 
and 31% among men diagnosed with distant (cancer has metastasized) prostate cancer (Fedewa, 
Etzioni, Flanders, Jemal, & Ward, 2010). A 100% relative survival rate means that men 
diagnosed with prostate cancer do not have excess mortality compared to men of a similar age 
and race (Hamilton & Ries, 2007).  
In a twelve year prospective cohort study, it was confirmed that there is a 100% relative 
survival rate for localized and regional prostate cancer cases for males of all races within for the 
first five years of diagnosis. However, African American men survival rate decreases slightly 
after three years of diagnosis due to metastasis or distance disease, compared to Caucasian 
Americans. Additionally, men diagnosed with prostate cancer under the age of sixty-five tended 
to have a lower survival rate compared to men diagnosed between the age of sixty-five and 
seventy-four years of age. The relative five year survival rate for all males between the age of 
twenty and seventy-five after diagnosis, by geographic location in the US was 100% for 
localized disease, 96% for regional disease, and 35.4 % for distant disease. However, the rural 
areas of Georgia accounted for the lowest survival rate during the fifth year after diagnosis 
(Hamilton & Ries, 2007).   
Populations based studies consistently show that African American men living in the US 
are more likely to be diagnosed with an aggressive form of prostate cancer and have a lower five 
year survival rate than men of other races when the disease is diagnosed at the same stage. 
Japanese American and Chinese American men tend to have higher survival rates of prostate 
cancer compared to both African American and Caucasian American men when they are 
diagnosed at a similar disease stage (Girvan et al., 2003). African American men are less likely 
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to be diagnosed with prostate cancer at a localized stage, when the disease can be successfully 
treated, and are more likely to be diagnosed at a distant stage when the cancer has spread to other 
regions of the body (Jemal et al., 2011).  
Advance stages of prostate cancer are the primary factor behind the poor survival rate. 
Access to and use of health care services may partially account for the poor survival rate of the 
disease. Lack of access to health care may be influenced by economic, social, and cultural factors 
that differ by race and nationality. Men of various races and/or nationalities may find difficulty 
in pursuit of adequate health care due to language barriers, specific cultural practices pertaining 
to medical care, and their socioeconomic status (SES). SES is associated to the usage and access 
of health care. Lower SES is related to a limited and a more uncommon use of health care 
services, and a higher incidence and mortality of prostate cancer (Girvan et al., 2003).     
Research among African American and Caucasian men indicate that SES may partially 
account for some or all of the racial difference in prostate cancer stage of diagnosis and survival. 
Additionally, aging increases the risk of developing prostate cancer and co-morbid conditions. 
Multiple studies among men with prostate cancer have found that co-morbid conditions influence 
the survival of men with prostate cancer by changing their treatment options (Girvan et al., 
2003). Additionally, multiple studies have confirmed that insurance status is strongly related to 
prostate cancer severity among males of all races.  
Primary Payer 
Men who have health insurance are less likely to die from prostate cancer (Fedewa et al., 
2010). Insurance status plays a vital role in receiving specific treatments, education, counseling 
services, and screening activities for prostate cancer (Sadetsky et al., 2008). The stage of prostate 
cancer among uninsured or Medicaid insured men is correlated with lower access to healthcare 
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services and the utilization of PSA testing. In a study conducted between 2004 and 2006, among 
men diagnosed with prostate cancer, found that uninsured and Medicaid insured men are more 
likely to have elevated PSA levels (Fedewa et al., 2010).       
Studies that examine the relationship between insurance, types of treatment, and prostate 
cancer survival, have yielded mixed results. In a study conducted, on Health Maintenance 
Organization (HMO) and Free-for-Service (FFS) Medicare patients, concluded that HMO 
patients diagnosed with prostate cancer between 1985 and 1992 were likely to receive aggressive 
treatment compared to patient in the FFS groups (Sadetsky et al., 2008). Another study, 
examining the patterns of treatments for men diagnosed with prostate cancer with and without 
insurance, found that older Caucasian men with private insurance were more likely to receive 
radical prostatectomy, and radiation therapy than other men in the study (Wu et al., 2005). 
A study examining whether the type of treatment men diagnosed with prostate cancer 
received differed by their type of insurance. Of the 13,124 men enrolled in the study twenty-
three percent were insured by Medicare, forty-forty percent were insured by Medicare plus a 
supplemental insurance such as Preferred Provider Organization (PPO), HMO, or FFS, and the 
remaining men were insured by HMO, PPO, or Veterans Affairs (VA). They found that men in 
the HMO, PPO, and VA group were more likely to receive hormonal treatment, and 
brachytherapy than radical prostatectomy when compared to men with Medicare only, Medicare 
and FFS, and Medicare and PPO. It was also found that men with VA coverage had the worst 
survival rate and were likely to have an aggressive form of prostate cancer at diagnosis (Sadetsky 
et al., 2008).   
The specific role insurance plays in receiving specific prostate cancer treatment remains 
uncertain. However, it has been suggested that insurance type influences the type of medical care 
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received through multiple mechanisms such as receiving services in a timely manner, receiving 
appropriate services which suits the patients' needs, and the access to continuity of care 
(Sadetsky et al., 2008).  
Insurance status is an important determinant in the different types of treatments received 
for prostate cancer (Sadetsky et al., 2008). In a 2007 study, analyzing America's uninsured 
population, it was found that fifty-five percent of males were uninsured, with sixty-two percent 
voluntarily uninsured, and fifty percent involuntarily uninsured. Uninsured men are unlikely to 
receive the appropriate treatment in a timely manner, thus increasing their odds of developing 
and dying from prostate cancer (O'Neill & O'Neill, 2007).  
Global Incidence & Mortality Rate Trends 
The effects of prostate cancer fluctuate among men throughout the world with a varying 
mortality and incidence rate. Globally, the incidence rates for African Americans ranks amongst 
the highest (185.4 per 100,000 individuals annually), followed by Caucasian Americans (107.8 
per 100,000 individually annually). The incidence rates in Brazil and the Caribbean tends to be 
higher in areas where there are larger populations of African descent (94 per 100,000 individuals 
annually). On the other hand, in some parts of Central America the incidence rate of prostate 
cancer are much lower in comparison (35 per 100,000 individuals annually) (Jemal et al., 2005).  
The incidence rates in Europe vary greatly, with the lowest rate in Eastern Europe (15 to 
36 per 100,000 individuals annually) and the highest in Western Europe, specifically in Austria 
(15 to 100 per 100,000 individuals annually). In Asia, the incidence of prostate cancer is much 
lower in comparison to the rest of the world. However, there is considerable variation within the 
more westernized countries such as Israel, Japan, and the Philippines (22 to 47 per 100,000 
individuals annually). Conversely in China, India, Pakistan, Shanghai, and Thailand the 
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incidence race is much lower (3 to 7 per 100,000) in comparison (Hsing & Chokkalingam, 
2006).  
The mortality rates tend to be higher in the Western nations and lower in Asian countries 
such as Korea, Japan, South Korea (2 to 5 per 100,000 individuals annually). Mortality rates are 
found to be higher in Scandinavian countries and northern Europe (19 to 23.6 per 100,000 
individuals annually) compared to the US (14 per 100,000 individuals annually). The highest 
prostate cancer mortality rates are found Caribbean nations of Barbados, Trinidad and Tobago, 
and the Bahamas where a large portion of men are of African descent (Jemal et al., 2005). 
Incidence & Mortality Rate Trend in the US & Ohio  
One in six men in the US who are diagnosed with prostate cancer will pass away within a 
few years of diagnosis (Jemal et al., 2005). It is estimated that 241,740 men will be diagnosed 
with and 28,170 men will pass away from prostate cancer in 2012. According to 2007 to 2009 
rates, approximately sixteen percent of men born in this generation will be diagnosed with 
prostate cancer at some point during their life (Howlader et al., 2012). The trend in the incidence 
rate throughout the US for all races from 2000 and to 2009 has decreased by 1.9%. The trend in 
mortality rate for prostate cancer for all races throughout the US from 1994 to 2004 decreased by 
3.9%, and from 2004 to 2009 decreased by 3.2% (Howlader et al., 2012). 
Prostate cancer affects about 1 out of every 11 Caucasian men, and 1 out of every 9 
African American men in the US. In 2009, there were approximately 27,360 deaths attributed to 
prostate cancer with 192,280 new cases of the disease in the US (Jemal et al., 2009). During 
2001 to 2005 the average annual age adjusted prostate cancer incidence rate in the US was 169.4 
per 100,000 males (Ohio Department of Health, 2012). During that time period, the average 
annual age adjusted prostate cancer incidence and mortality rate in the State of Ohio was 145.7 
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per 100,000 males or 7,706 new cases and 27.8 per 100,000 males or 1262 deaths respectively 
(Ohio Department of Health, 2012). 
From 2005 to 2009, the median age at diagnosis and mortality for prostate cancer was 
sixty-seven and eighty years old respectively (Howlader et al., 2012). Men who were diagnosed 
and died between the age of 35 and 44 accounted for 0.6% and 0.1% respectively; 45 to 54 
accounted for 9.5% and 1.5% respectively; 55 to 64 accounted for 31.6% and 8.0% respectively; 
65 to 74 accounted for 35. 5% and 19.8% respectively; 75 to 84 accounted for 18.6% and 38.6% 
respectively; and 85 years and above accounted for 4.1% and 32.0% respectively. During those 
years the incidence and mortality rate for all races was 154.8 and 23.6 per 100,000 men 
respectively; 146.9 and 21.7 per 100,000 Caucasians men respectively; 236 and 53.1 per 100,000 
African Americans men respectively; 85.4 and 10 per 100,000 Asian/Pacific Islanders men 
respectively; and 125.9 and 17.8 per 100,000 Hispanics men respectively (Howlader et al., 
2012).  
Prostate cancer in Ohio is the second leading cause of cancer deaths among men, 
following lung cancer. It is the most frequent invasive cancer diagnosed in men living in Ohio. It 
represents 10% of all male cancer deaths. African American men in Ohio are two times as likely 
to pass away from the disease, compared to Caucasian men. Prostate cancer death rates 
decreased by 39.8% for Caucasian men and 35.9% for African American men throughout the 
state from 1992 to 2006 (Ohio Department of Health, 2009).   
The average annual population for Montgomery County during 2001 to 2005 was 
550,564, of which 73% was age 20 and older and 31% was age 50 and older. Additionally, the 
population was 48% male and 21% African American men. During that time period the 
Montgomery County prostate cancer incidence and mortality rate for all males was 140.8 per 
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100,000 males or 2796 new cases and 25.5 per 100,000 males or 1,228 deaths respectively, 
which was lower than the state of Ohio incidence and mortality rate and the US incidence and 
mortality rate of 163.0 per 100,000 males and 26.7 per 100,000 males respectively (Ohio 
Department of Health, 2009). 
Methods 
A descriptive study of prostate cancer was conducted on Montgomery County men using 
the Ohio Cancer Incidence and Surveillance System (OCISS) Data, 2000-2009. The OCISS data 
was obtained from the faculty adviser overseeing the study from the Ohio Department of Health, 
and was used to determine the incidence and mortality rate, the current trend, and a descriptive 
analysis of men with of prostate cancer in the county. The data was compared to other counties 
of similar demographics, Ohio, and the US. Approval for this study was granted by Wright State 
University Institutional Review Board on April 20, 2012. 
The primary prostate cancer prevention factors assessed for Montgomery County men 
includes: the average annual population estimates from 2000-2009; a socioeconomic profile of 
men living in Montgomery county; prostate cancer related risk factors such as primary payer, 
PSA testing, heavy drinking, smoking, weight, and fruit and vegetable consumption; an in-depth 
analysis of men age 35 and older who consume less than five servings of fruits and vegetables; 
and an in-depth analysis of men who reported having a PSA test within the last two years. 
Secondary data sources accessed for incidence, mortality and trend analysis are listed below: 
• United States Census Bureau 
• Surveillance Epidemiology and End Results  
• Ohio Health Jurisdiction Cancer Profiles, Ohio Cancer Incidence Surveillance    
System, Ohio Department of Health 
• 2009 Behavioral Risk Factor Surveillance System 
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• 2008 Healthy Ohio Community Profiles 
• National Cancer Institute 
The total number of men over the age of 18 who consume less than 5 servings of fruits 
and vegetables per day living in Montgomery County in 2007 was used to calculate the other 
years for Montgomery County. The 2007 percentage was retrieved from the Montgomery 
County Health Assessment 2010. The percentage of men who consume less than 5 serving per 
day in 2007 was divided by the percent who consume less than 5 servings in Ohio in 2007. It was 
then multiplied by the other Ohio years to determine the percentages for Montgomery County.   
The total number of men over the age of 40 who received a PSA test in Montgomery 
County was used to calculate the other categories for Montgomery County. This percentage was 
retrieved from the BRFSS. The total number of men living in Montgomery County was divided 
by the total number for Ohio and multiplied by the other Ohio categories to determine the 
percentages for Montgomery County.   
The early detection factors assessed for Montgomery County include: incidence and 
mortality rates for prostate cancer; incidence and mortality rates for all cancer sites; prostate 
cancer incidence, mortality, screening, and late stage diagnosis; the average annual numbers and 
the percent of prostate cancer cases in the county; the trend of invasive prostate cancer incidence 
compared to other counties; prostate cancer by grade, age group and race; and prostate cancer 
incidence rate by staged at diagnosis. Secondary data sources for the early detection factors are 
listed below: 
 Ohio Cancer Incidence Surveillance System, Ohio Department of Health 
 Ohio Public Information Warehouse, Ohio Department of Health 
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 Cancer Incidence and Mortality among Ohio Residences, 2003-2007. Ohio 
Cancer Incidence Surveillance System, Ohio Department of Health, August 2010. 
Additionally, the Ohio Cancer Incidence and Surveillance System (OCISS) data for men 
living in Montgomery County with prostate cancer was used to calculate the incidence and 
prevalence of prostate cancer by the stage at diagnosis.  
A descriptive analysis was created with the data acquired from the OCISS. The variables 
used included marital status, city, zip code, race, gender, age of diagnosis, and primary payer at 
diagnosis.  
Results 
Primary Prevention Factors 
Table 1. Average Annual Population Estimates for Montgomery County by Age Group, 
Gender, and Race, 2000-2009
1,3,4 
Age Group Gender Race Total 
Population2 Male Female Caucasian African 
American 
<20 73,639 70,655 99,890 36,889 144,294 
20+ 187494 211,071 312,585 73,394 398,565 
40+ 116,902 144,668 204,464 44,468 261,570 
50+ 78,433 104,071 144,311 30,002 182,504 
All ages 261,133 281,726 412,475 110,283 542,859 
1
The 2000-2009 population estimates for Montgomery County Ohio was determined by averaging the postcensal 
estimates for    
  July 1, 2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009 U.S. Census Bureau, 2010.    
2
Total population includes whites, blacks, and all additional races.  
3 Vintage 2006 postcensal estimates for July 1, 2001-2005, U.S. Census Bureau, 2007 
4 Data Source: Census 2000 - 2009 Demographic Profiles, U.S. Census Bureau, Summary File 1(SF1) 
 
The 2000 to 2009 average annual population, presented in Table 1, for Montgomery 
County is 542, 859, of which 48 percent are age 40 and older and 34 percent are age 50 and 
older. The population is 48 percent male, 52 percent female, 76 percent Caucasian, and 20 
percent African American. Nationally and in Ohio, prostate cancer incidence rates are higher 
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among African American men compared to Caucasian men. Additionally, the risk of prostate 
cancer increases with age. 
Table 2. Socioeconomic Profile of Montgomery County with Comparison to Ohio & the US
1,2 
Socioeconomic Indicators Montgomery 
County 
Ohio US 
Median Earnings for Male Full-Time, 
Year-Round Workers ($) 
45,680 46,106 46,478 
Median Household Income ($) 56,559 59,680 62,982 
% Families Below Poverty Level 11.7% 10.3% 10.1% 
% No High School Diploma (Age 25+) 9.0% 9.2% 8.7% 
% Uninsured
3
 12.4% 18.5% 16.7% 
1
Table adapted from Montgomery County Cancer Profiles, Ohio Cancer Incidence Surveillance System, Ohio 
Department of Health, 2008. 
2
Data Source: U.S. Census Bureau, 2006-2010 American Community Survey. 
3
Percent of uninsured adults in Ohio Counties: Ohio Family Health Survey (Adults 18-64), 2008.  
Socioeconomic indicators related to the risk of developing and dying from prostate 
cancer in Montgomery County, Ohio, and the US are presented in Table 2. The factors include: 
median earnings for male full-time year round workers, median household income, percentage of 
families below the poverty level, percentage of people who did not attain a high school diploma, 
and those who are uninsured. The median earnings for male full-time workers in Montgomery 
County is approximately on par with Ohio and the US; however the median household income is 
considerable less when compared to Ohio and the US. Montgomery County has a higher 
percentage of families living below the poverty level compared to Ohio and the US. The 
percentage of people without a high school diploma in the county is higher than the national 
percentage, but lower than Ohio. Lastly, Montgomery County has a lower percentage of 
uninsured people compared to Ohio and nationally. 
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Table 3. Prostate Cancer and Cancer Related Health Behaviors/Risk Factors
1 
        
1
Data Source: 2007 Ohio Behavioral Risk Factor Surveillance System (BRFSS), ODH     
            2
2008 data used from Ohio Behavioral Risk Factor Surveillance System (BRFSS), ODH   
 
There is not large variation among the counties listed with regards to the percent of 
people who consume less than five fruits or vegetables per day, the percent of current smokers, 
the percent of overweight and obese, and the percent of physical inactivity. Montgomery County 
has the highest percentage with regards to the percent of overweight people compared to the 
national average, the State of Ohio, and the other counties. Compared to the national average, 
Montgomery County is approximately four percentage points higher for those who smoke 
tobacco, and three percentage points lower for those who are considered obese.  
Montgomery County also has a larger percentage of people who eat less than five fruits 
or vegetable servings per day compared to the national average. Additionally, Montgomery 
County is above the national average for the percent of men, age forty and older, that have had a 
PSA test within the last two years. Age is a strong risk factor for prostate cancer; men under the 
age of fifty are rarely diagnosed with the disease. 
 
  
County 2007 
Population 
% of Men 
age 40+ 
who had a 
PSA test in 
the past 2 
years
2
 
%  
<5 
Fruit/Veg 
%  
Heavy 
Drinkers 
% 
Current 
Smokers 
%  
Over 
weight 
% 
Obese 
% No 
physical 
Activity 
Montgomery 538,104 56.0 77.7 5.3 23.2 38.3 23.1 47.6 
Lucas 441,910 56.0 82.3 5.1 24.4 35.7 30.6 50.4 
Stark 378,664 61.8 78.4 4.3 24.5 35.8 28.5 50.1 
Summit 543,487 58.9 77.2 5.7 21.8 36.6 26.3 49.7 
Ohio  11,466,917 54.6 79.2 5.5 23.1 35.4 28.1 50.0 
US 301,621,159 54.8 75.7 5.2 19.7 36.7 26.3 50.8 
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Table 4. % of Men 35+ who reported consuming less than 5 servings of fruits/vegetables per 
day, 2000-2009
1  
% of Men who consume less than 5 servings per day 
Year US Ohio Montgomery County
2
 
2000 81.1 82.3 81.6 
2001 79.9 77.1 76.5 
2003 82.4 81.4 80.7 
2005 81.4 81.9 81.2 
2007 80.6 84.7  84.0
3
 
2009 80.8 82.9 82.2 
             1
Data Source: 2010 Ohio Behavioral Risk Factor Surveillance System (BRFSS), ODH     
         
2
Data includes men 18 years and older  
         
3
Data Source: Montgomery County Community Health Assessment 2010 
 
A diet rich in fresh fruits and vegetables, serves as a protective factor that may lower 
incidence rate of prostate cancer. The percentage of men from 2000-2009 who consume less than 
five servings of fruits/vegetables per day in Montgomery County was estimated from the Ohio 
BRFSS data. There was not a huge disparity among men consuming less than 5 servings of fruits 
and vegetables within the past ten years in Montgomery County compared to Ohio, and 
nationally. However, during that period, Montgomery County had slightly more men on average 
who consume less than 5 servings of fruits and vegetables compared to the national average.  
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Table 5. % of Men 40+ who reported having had a Prostate Specific Antigen (PSA) test1  
 
% of Men age 40+ had a PSA test in the past 2 years 
 
US Ohio 
Montgomery 
County
2
 
Category 
   
Age 
                  40-49 26.0 24.7 25.3 
               50-59 56.1 56.1 57.4 
               60-64 72.5 72.4 74.1 
               65+ 76.2 79.3 81.2 
 
   Race 
                  Caucasian 54.8 55.0 56.3 
               African American 58.8 57.5 58.9 
               Hispanic 40.6 N/A N/A 
               Other 43.4 N/A N/A 
    Education 
                  Less Than High School 40.4 40.2 41.2 
               High School or GED 49.3 51.3 52.5 
               Some College 54.3 54.8 56.1 
               College Graduate 59.6 59.4 60.8 
    Annual Household Income 
                  < $15,000 36.5 33.9 34.7 
               $15,000 - 24,999 47.3 56.5 57.9 
               $25,000 - 49,999 52.9 57.8 59.2 
               $35,000 - 49,999 56.1 57.3 58.7 
               $50,000+ 55.7 55.0 56.3 
    Total (Men 40+) 53.2 54.4 55.7
3
 
1
Data Source: 2010 Ohio Behavioral Risk Factor Surveillance System (BRFSS), ODH 
2
Data Source: Estimated based on Ohio data 
3
Data Source: 2010 Ohio Behavioral Risk Factor Surveillance System (BRFSS), ODH 
  
The PSA test measures the level of PSA in the blood. The test was approved by the US 
Food and Drug Administration (FDA) to help detect prostate cancer in men age 50 and older. 
Table 4 shows percentage of men age 40 and older nationally, in the state of Ohio, and 
Montgomery County who reported having a PSA test within the last two years. The percentages 
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for Montgomery County were estimated based on the 2010 BRFSS estimates for Ohio. From the 
Montgomery County estimates, the frequency of men who had a PSA test within the past two 
years increased with age. There was only a slight difference in PSA testing by race. Male college 
graduates were more likely to have had a PSA test than men with less than a high school 
education. Lastly, there was great disparity in PSA testing between men who have an annual 
income of less than $15,000 per year and men whose annual income in greater than $15,000 
annually.    
Early Detection Factors  
Table 6. Average Annual Number and Age-adjusted Rates of Invasive Cancer Cases and 
Cancer Deaths for All Sites/Types in Montgomery County with Comparisons to Ohio and the 
US, 2003-2007
1, 2 
 
  All Cancer Sites/Types 
 Incidence Mortality  
 County
3
 Cases Rate per 100,000 Cases Rate per 100,000 
Montgomery 2,909 473.2 1,210 193.7 
Lucas 2,213 476.3 982 208.8 
Stark 2,048 453.6 862 184.5 
Summit 2,815 460.9 1,240 199.2 
Ohio 29,591 470.0 12,859 199.6 
United States - 461.6 - 183.8 
1
Source: Chronic Disease and Behavioral Epidemiology and the Vital Statistics Program, Ohio Department of  
Health, 2010; National Center for Health Statistics Public Use Mortality Data published in SEER Statistics Review 
1975-2007, National Cancer Institute, 2010 
2
Average annual rate per 100,000, age-adjusted to the 2000 US standard population  
3
Source: Ohio Cancer Incidence Surveillance System, Ohio Department of Health, 2010 
 
Montgomery County cancer incidence rate for all sites/types combined was 473.2 cases 
per 100,000 individuals or 2,909 cases per year from 2003 to 2007. This rate is second only to 
Lucas County (476.3 cases per 100,000 individuals), and higher than the incidence rate for Ohio 
and the US (Table 6). The mortality rate for cancer mortality for all sites/types accounted for 
193.7 cases per 100,000 individuals, which is higher than the national rate (183.8 cases per 
100,000 individuals), but lower than the rate in Ohio (199.6 per 100,000 individuals). 
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Montgomery County mortality rate for all site/types ranked third behind Lucas and Summit 
Counties.   
Table 7. Prostate Cancer Incidence, Mortality, Screening, and Late Stage Diagnosis for 
Montgomery and comparison counties, Ohio, and the United States, 2003-2007
1, 2 
 
  Rate per 100,000 Percent 
County 2007 Population Incidence1 Mortality1  Men age 40+ who 
had a PSA test in the 
past 2 years2 
Late 
Stage 
DX1 
Montgomery 538,104 151.4 23.1 56.0 9.0 
Lucas 441,910 147.7 24.5 56.0 10.0 
Stark 378,664 154.5 23.5 61.8 11.0 
Summit 543,487 135.2 31.1 58.9 11.0 
Ohio 11,466,917 145.5 26.2 54.6 10.0 
United States3 301,621,159 156.9 24.7 54.8 4.2 
1
Source: Ohio Cancer Incidence Surveillance System, Ohio Department of Health, 2010 
2
Source: Ohio Behavioral Risk Factor Surveillance System (BRFSS), Ohio Department of Health, 2008   
3
Data source: Surveillance Epidemiology and End Results (SEER) Program, National Cancer Institute (US data), 
2008  
 
From 2003 to 2007, Montgomery County had the third highest prostate cancer incidence 
compared to Ohio, the United States, and other counties in Ohio with comparable population 
sizes and demographics. From 2003 to 2007, Montgomery County had the lowest prostate cancer 
mortality rate (23.1 per 100,000) compared to the other counties, Ohio, and the US. Additionally, 
Montgomery County had the third highest percent of males who had a PSA test within the last 
two years. Montgomery County had a lower percentage of men who were diagnosed with 
prostate cancer at a late stage than the Ohio average.  
  
MONTGOMERY COUNTY PROSTATE CANCER                                                               44 
Figure 1: Prostate Cancer: Age specific Proportions (%) by Race in Montgomery County, 
2000-2009a 
 
a
Data Source: Ohio Cancer Incidence Surveillance System (OCISS), 2008-2009 
  
Figure 1 shows the 2000 to 2009 age-specific proportions for prostate cancer by race. 
Virtually all of the prostate cancer cases diagnosed in Montgomery County during that time 
period were among men age 40 and older. Among Caucasian men, the proportion of prostate 
cancer increased with advancing aging starting from the 40-49 age group, peaking at the 60-69 
age group, and declining beyond that age group. A similar trend can be seen with the African 
American men age group. Among men classified as other/unknown, prostate cancer incidence 
rates increased with advancing aging, starting from the 40-49 age group, but peaking at the 70-79 
age group. Overall, the proportion of prostate cancer increases for all races beyond the age of 40. 
However, the proportion begins to decrease between the age of 60 and 79 for all races.     
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Table 8. Average Annual Number and Percent of Prostate Cancer Cases, by County of Residence and Stage at Diagnosis, 2003-
2007
1 
1
Data Source:  Cancer Incidence and Mortality among Ohio Residences, 2003-2007. Ohio Cancer Incidence Surveillance System, Ohio Department of Health, 
August 2010. 
In situ is an early form of cancer that is defined by the absence of tumor cells into the surrounding tissue. A localized stage 
cancer diagnosis is considered an early stage diagnosis in which the invasive cancer is confined to the organ of origin. Regional stage 
is considered a late stage diagnosis and corresponds to a direct extension to neighboring organs or tissues or the involvement of the 
regional lymph nodes. Distant stage is a late stage diagnosis that is correlated with a higher cancer mortality rate because the cancer 
has metastasized to parts of the body.  
Montgomery County had the highest total prostate cancer cases compared to the other counties. Montgomery County had the 
lowest percent of localized (82.2%) and distant stage (2.8%) at diagnosis in comparison to Ohio and the other counties. Additionally, 
Montgomery County had the second highest percent of regional stage (6.7%) at diagnosis in comparison to the other metropolitan 
counties. Montgomery County was on par with in situ (0.3%) at diagnosis compared to the other counties. 
  In situ Localized Regional Distant Unstaged/Unknown Total 
  Cases Percent Cases Percent Cases Percent Cases Percent Cases Percent Cases 
Montgomery 1 0.3 337 82.2 27 6.7 9 2.8 33 8.3 407 
Lucas 0 0 253 86.5 18 6.4 11 3.8 9 3.2 291 
Stark 1 0.3 260 83.7 25 8.1 9 3.1 16 5 311 
Summit 1 0.3 304 84.4 24 6.8 14 3.9 17 4.8 360 
Ohio 3 0.02 6,630 83.2 555 6.9 269 3.4 506 5.5 7963 
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Figure 2. Staged Prostate Cancer Trends, Montgomery County, Ohio, 2000-2009 a  
 
 
a
Data Source: Ohio Cancer Incidence Surveillance System (OCISS), 2000-2009 
 
In Montgomery County, from 2000 to 2009, the localized (early) stage of prostate cancer 
diagnosis is ranked the highest among all stages followed by in situ (early), regional (late), 
distant (late), and unknown (Figure 2). Comparing prostate cancer stage according to the spread 
or variability of data, localized stage has the most variability followed by unstaged/unknown, 
regional, distant and in situ. 
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Figure 3. Trends in the Proportion of Cases (%) by All Stages at Diagnosis in Montgomery 
County, Ohio, 2000-2009 a  
 
 
a
Data Source: Ohio Cancer Incidence Surveillance System (OCISS), 2000-2009 
 
Figure 3 shows the distribution of all stages at diagnosis of prostate cancer by race and 
year of diagnosis from 2000 to 2009. During this time period, compared to African American 
men and men of other/unknown races, a larger proportion of Caucasian men were diagnosed 
with prostate cancer. This is because Caucasians make up a larger portion of the population.  
However, from 2007 to 2008, Caucasian men diagnosed with prostate cancer decreased by four 
percentage points, but then increased by six percentage points from 2008 to 2009. The trend was 
reversed for African American men during the 2007 to 2008 period; during that period, African 
American men diagnosed with prostate cancer increased by seven percentage points but then 
decreased by seven percentage points between 2008 and 2009. From 2000 to 2009 men of other 
and unknown races remained relatively constant.  
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Table 9. Incidence rates for prostate cancer, by stage at diagnosis
ab 
 
US  2001-2007 
                 Stage at 
diagnosis  Rate 
                 In situ 0.0 
                 Localized  82.0 
                 Regional  11.0 
                 Distant  4.0 
                 Unstaged  3.0 
                 
                     Montgomery 
County  2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Stage at 
diagnosis -  Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate n 
In situ 0 0 0 0 0 0 0.3 1 0 0 0 0 0 0 0 0 0 0 0 0 
Localized  70.9 272 70.9 249 78.9 302 77.6 281 80.4 307 85.8 337 87.4 396 79.7 366 78.2 327 78.3 293 
Regional  5.1 19 8 28 6.8 26 6.6 24 7.9 30 7.4 29 4.9 22 6.8 31 6.0 25 8.3 31 
Distant  4.9 18 4.6 16 1.8 7 2.8 10 3.9 15 1.3 5 2.9 13 3.1 14 2.9 12 4.0 15 
Unstaged  16.3 60 16.5 58 12.5 48 12.7 46 7.9 30 5.6 22 4.9 22 10.5 48 12.9 54 9.4 35 
                     Montgomery 
County 2000-2002 2003-2007 2008-2009 
 
             Stage at 
diagnosis -  Rate Rate Rate 
              In situ 0.0 0.1 0.0 
              Localized  73.6 82.2 78.3 
              Regional 6.6 6.7 7.1 
              Distant  3.8 2.8 3.4 
              Unstaged  15.1 8.3 11.1 
              
a 
New cases diagnosed per 100,000 Males   
b
Data Sources:  Ohio Cancer Incidence Surveillance System (OCISS), 2000-2009, Ohio Department 
of Health; National Cancer Institute (US data) 
c 
Incidence calculated using 2000 Census Data 
  
Rates for localized prostate cancer increased substantially from 2000 to 2006, but decreased slightly 
from 2007 to 2009 
 
Rates for regional prostate cancer increased slightly from 2000 to 2001, but decreased slightly from 
2001 to 2003. From 2003 to 2009 the rates fluctuated with an overall increasing trend.   
Rates for distant prostate cancer decreased from 2000 to 2002, increased from 2003 to 2004, and 
fluctuated slightly from 2005 to 2009. 
 
Rates of unstaged prostate cancer for Montgomery County is higher than US. 
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Table 10: Percent distribution by grade (Cell Differentiation), Age group and Race in 
Montgomery County, 2000-2009
1
 
Grade Caucasian African 
American 
Other/Unknown 
Age <65    
Well differentiated; Grade 1 0.7 2.0 0.4 
Moderately differentiated; Grade 2 20.2 21.9 18.6 
Poorly differentiated; Grade 3 11.8 13.8 5.3 
Undifferentiated; anaplastic; Grade 4 0.1 0.9 0.0 
Unknown 1.4 1.8 4.5 
    
Age ≥ 65    
Well differentiated; Grade 1 1.5 2.3 0.8 
Moderately differentiated; Grade 2 32.6 26.8 31.4 
Poorly differentiated; Grade 3 23.4 20.5 24.6 
Undifferentiated; anaplastic; Grade 4 0.5 0.9 0.8 
Unknown 7.9 9.2 13.6 
a
Data Source: Ohio Cancer Incidence Surveillance System (OCISS), 2000-2009 
Table 10 shows the distribution of prostate cancer in Montgomery County by grade, age 
group and race. Grade 1 represents the least atypical and aggressive form of cancer with well 
differentiated cells. Grade 2 represents prostate cells that have maintained their normal 
characteristics (moderate differentiation). Grade 3 represents poorly differentiated cells or an 
atypical and aggressive form of prostate cancer. Grade 4 represents undifferentiated cell, which 
is also the most aggressive form of prostate cancer.     
From 2000 to 2009, the grade distribution did not differ noticeably by age group or race. 
The majority of males living in Montgomery County during this time period were diagnosed 
with moderately differentiated (grade 2) and poorly differentiated (grade 3) prostate cancer, 
despite age group or race.   
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Figure 4. Invasive Prostate Cancer Incidence Trend of Montgomery and other 
metropolitan counties of Ohio, 1998-2007
a
 
a
Data Source:  Ohio Department of Health, Ohio Public Health Information, 
http://publicapps.odh.ohio.gov/pwh/pwhmain.aspx 
Overall, the incidence trend for prostate cancer in Montgomery County from 1998 to 
2007 appears generally consistent. However, from 2004 to 2007, the invasive prostate cancer 
incidence trend appears to be increasing. Additionally, from 1998 to 2004, the trend for 
Montgomery County was lower than the Ohio, Summit, and Lucas County. Ohio data seems 
more stable compared to the county data, which may be due to the number of cases in the state 
during that time period.  
Notes: 
Invasive Prostate Cancer is a malignant tumor that originates in the prostate, and then 
spreads into nearby healthy tissue. It may require a more insistent treatment approach 
than in situ prostate cancer.  
Malignant tumors pertain to a tumor that can potentially invade and destroy neighboring 
tissue and metastasize to other regions of the body. 
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Figure 5. Prostate Cancer Mortality Trend of Montgomery and other metropolitan 
counties in Ohio, 2000-2008
a 
 
a
Data Source:  Ohio Department of Health, Ohio Public Health Information, 
http://publicapps.odh.ohio.gov/pwh/pwhmain.aspx 
Prostate cancer mortality rate in Montgomery County from 2006 to 2008 decreased by 
2.5 percentage points from 2000 to 2002. During 2006 to 2008, Montgomery County had the 
third lowest rate of prostate cancer mortality compared to Ohio and the other metropolitan 
counties in the State.   
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Figure 6. Average Annual Age-adjusted Incidence Rates of Invasive Prostate Cancer, by 
Census Tract, in Montgomery County, 1996-2005
1-4
 
 
1
Source: Ohio Cancer Incidence Surveillance System, Ohio Department of Health, 2008. 
2
Rates are per 100,000 and were calculated using vintage 2006 intercensal estimates for July 1, 1996-1999 and 
postcensal estimated for July 1, 2000-2005, (U.S. Census Bureau, 2007). Rates are direct age adjusted to the U.S. 
2000 standard population.  
3
NOTE: Large census tracts may appear to have higher rates and risks due to their size -interpret with caution. 
4
Cut points for rate quartiles were derived from the distribution for the State of Ohio.  
*Rates may be unstable and are not presented when the count for 1996-2005 is less than five (i.e., average annual 
count is <1). A number (less than 1%) of unusually high outlying incidence rates are also not presented.   
 
The incidence rate of prostate cancer appears to be higher in larger census tracts. 
However, as referenced above, they appear to have higher rates because of their size. Therefore, 
the higher incidence rates for prostate cancer may not have a particular trend in a specific region.  
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Descriptive Analysis of Men with Prostate Cancer in Montgomery County
 
Table 11. Characteristics of Montgomery County Men with Prostate Cancer 2000-2009
1
 
 Total  Early Stage 
Diagnosis 
 Late Stage 
Diagnosis 
         
Category  n %  n %  n % 
      Total  3971 100  3130 100  399 100 
         
Demographics          
     Race/Ethnicity          
     Caucasian  2805 70.6  2227 71.2  294 73.7 
     African American  883 22.2  699 22.3  91 22.8 
     Other/Unknown 283 7.2  204 6.5  14 3.5 
         
Age at Diagnosis          
     <40 4 0.1  4 0.1  0 0.0 
     40-49 88 2.2  64 2.0  19 4.8 
     50-59 686 17.3  561 17.9  95 23.8 
     60-69 1410 35.5  1179 37.7  140 35.1 
     70-79 1259 31.7  1025 32.7  86 21.6 
     80-89 464 11.7  279 8.9  53 13.3 
     90+ 60 1.5  18 0.6  6 1.5 
         
City of Diagnosis         
     Beavercreek 13 0.3  9 0.3  1 0.3 
     Brookville 109 2.7  89 2.8  12 3.0 
     Carlisle 3 0.1  3 0.1  0 0.0 
     Centerville 267 6.7  209 6.7  26 6.5 
     Clayton 39 1.0  33 1.1  5 1.3 
     Dayton 2063 52.0  1626 52.0  208 52.1 
     Englewood 130 3.3  114 3.6  10 2.5 
     Farmerville 20 0.5  14 0.4  4 1.0 
     Germantown  57 1.4  45 1.4  3 0.8 
     Huber Heights 222 5.6  182 5.8  29 7.3 
     Kettering  345 8.7  262 8.4  34 8.5 
     Miamisburg 194 4.9  148 4.7  19 4.8 
     Middletown 1 0.0  1 0.0  0 0.0 
     Moraine 30 0.8  23 0.7  2 0.5 
     New Lebanon  43 1.1  35 1.1  6 1.5 
     Jefferson Township 1 0.0  0 0.0  0 0.0 
     Oakwood 1 0.0  0 0.0  0 0.0 
     Perry Township 1 0.0  0 0.0  0 0.0 
     Phillipsburg 4 0.1  4 0.1  0 0.0 
     Riverside 4 0.1  3 0.1  1 0.3 
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 Total  Early Stage 
Diagnosis 
 Late Stage 
Diagnosis 
     Springboro 2 0.1  1 0.0  0 0.0 
     Tipp City 1 0.0  1 0.0  0 0.0 
     Trotwood 134 3.4  103 3.3  14 3.5 
     Union  36 0.9  33 1.1  3 0.8 
     Vandalia 103 2.6  82 2.6  10 2.5 
     Washington Twp. 43 1.1  26 0.8  3 0.8 
     West Alexandria 3 0.1  3 0.1  0 0.0 
     West Carrollton 99 2.5  78 2.5  9 2.3 
     Xenia 1 0.0  1 0.0  0 0.0 
                  
Marital Status          
     Single  260 6.5  195 6.4  42 10.8 
     Married 2542 64.0  2126 69.7  256 65.6 
     Divorce/Separated 300 7.6  230 7.5  34 8.7 
     Widowed 302 7.6  191 6.3  39 10.0 
     Unknown  447 11.3  309 10.1  19 4.9 
         
Primary Payer         
     Not Insured  54 1.4  30 1.4  1 0.5 
     Private Insurance 1028 25.9  428 19.4  61 29.9 
     Medicaid  50 1.3  22 1.0  3 1.5 
     Medicare 1921 48.4  792 35.8  104 51.0 
     Military  62 1.6  2 0.1  0 0.0 
     Insured NOS 308 7.8  140 6.3  16 7.8 
     Unknown 369 9.3  797 36.0  19 9.3 
         
Zip Code of Diagnosis         
     45005 3 0.1  3 0.1  0 0.0 
     45066 2 0.1  1 0.0  0 0.0 
     45237 1 0.0  1 0.0  0 0.0 
     45042 1 0.0  1 0.0  0 0.0 
     45309 110 2.8  89 2.8  12 3.0 
     45315 39 1.0  33 1.1  5 1.3 
     45322 166 4.2  147 4.7  13 3.3 
     45325 20 0.5  14 0.4  4 1.0 
     45327 57 1.4  45 1.4  3 0.8 
     45342 192 4.8  146 4.7  19 4.8 
     45343 2 0.1  2 0.1  0 0.0 
     45345 43 1.1  35 1.1  6 1.5 
     45354 4 0.1  4 0.1  0 0.0 
     45371 1 0.0  1 0.0  0 0.0 
     45377 105 2.6  82 2.6  10 2.5 
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 Total  Early Stage 
Diagnosis 
 Late Stage 
Diagnosis 
     45381 3 0.1  3 0.1  0 0.0 
     45401 1 0.0  1 0.0  0 0.0 
     45402 89 2.2  60 1.9  13 3.3 
     45403 62 1.6  50 1.6  5 1.3 
     45404 48 1.2  37 1.2  3 0.8 
     45405 128 3.2  100 3.2  13 3.3 
     45406 187 4.7  146 4.7  21 5.3 
     45407 1 0.0  1 0.0  0 0.0 
     45408 17 0.4  10 0.3  3 0.8 
     45409 39 1.0  31 1.0  6 1.5 
     45410 63 1.6  50 1.6  5 1.3 
     45413 3 0.1  1 0.0  0 0.0 
     45414 167 4.2  140 4.5  13 3.3 
     45415 122 3.1  104 3.3  11 2.8 
     45416 56 1.4  42 1.3  6 1.5 
     45417 324 8.2  260 8.3  31 7.8 
     45418 9 0.2  3 0.1  1 0.3 
     45419 104 2.6  80 2.6  13 3.3 
     45420 119 3.0  91 2.9  9 2.3 
     45422 3 0.1  0 0.0  0 0.0 
     45424 332 8.4  277 8.9  40 10.0 
     45426 161 4.1  128 4.1  15 3.8 
     45427 26 0.7  12 0.4  2 0.5 
     45428 3 0.1  1 0.0  0 0.0 
     45429 255 6.4  199 6.4  28 7.0 
     45431 66 1.7  49 1.6  7 1.8 
     45432 50 1.3  45 1.4  3 0.8 
     45434 2 0.1  1 0.0  0 0.0 
     45437 2 0.1  1 0.0  1 0.3 
     45439 67 1.7  53 1.7  3 0.8 
     45440 103 2.6  78 2.5  11 2.8 
     45449 127 3.2  96 3.1  13 3.3 
     45458 191 4.8  137 4.4  26 6.5 
     45459 292 7.4  238 7.6  25 6.3 
     45470 1 0.0  0 0.0  0 0.0 
     45475 1 0.0  0 0.0  0 0.0 
 
Other 
        
Prostate Cancer Survival 
              Yes                                        
               No 
 
3306
665 
 
 
83.3 
16.7 
 
 
 
 
2797 
333 
 
89.4 
10.6 
 
 
 
 
298 
101 
 
74.7 
25.3 
1
Data Sources: Ohio Cancer Incidence Surveillance System (OCISS), 2000-2009, ODH 
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Those diagnosed with prostate cancer in Montgomery County were primarily men 
between the age of 60 to 79, Caucasian men, married men, and men who used Medicare as their 
primary source of healthcare. The men within these groups were more likely to be diagnosed 
with early stage prostate cancer.   
Additionally, men living in the City of Dayton and within the 45424 zip code had the 
highest percentage of prostate cancer diagnosis, 52% and 8.4% respectively, compared to the 
other cities and zip codes in Montgomery County. However, men living within those regions 
were more likely to be diagnosed with early stage prostate cancer. Men who used Medicare as 
their primary source of healthcare had the highest percentage of prostate cancer diagnosis of all 
primary payers. Thirty-six percent of men on Medicare were diagnosed with early stage prostate 
cancer and fifty-one percent were diagnosed with late stage prostate cancer. 
Lastly, men were more likely to survive with early or late stage diagnosis during that time 
period than men who passed away from the disease. Overall, men living in the county were more 
likely to be diagnosed with early stage prostate cancer compare to late stage diagnosis. 
Table 12. Evaluating health differences by Race
1
 
 
Race Living % Deceased % 
Caucasian 2318 70.1 487 73.2 
African American 734 22.2 149 22.4 
Other/Unknown 254 7.7 29 4.4 
Total 3306 100.0 665 100.0 
1
Data Source: Ohio Department of Health, Ohio Cancer Incidence Surveillance System, 2000-2009. 
There is a difference among Caucasian men diagnosed with prostate cancer, when 
compared to African American men and men of other or unknown races. During the ten year 
time period, 70.1 percent of all prostate cancer cases were Caucasian men and 73.2% of all who 
died from prostate cancer were Caucasian men.  
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Discussion 
Primary Prevention Factors 
The primary prostate cancer risk factors assessed included age, race, and socioeconomic 
status. Prostate cancer related health factors such as smoking, alcohol abuse, tobacco use, 
overweight/obesity, physical inactivity, fruit and vegetable consumption, and PSA testing were 
also assessed.  
The 2000 to 2009 Montgomery County population was comprised of more women than 
men and a greater amount of Caucasians than African Americans. Examining the socioeconomic 
status for Montgomery County, the median income was lower than the state and national 
average. The median earnings for male full time workers were slightly lower than the national 
average and Ohio. Additionally, the percentage of families living below the poverty level was 
greater than Ohio and the US.  
During that period there were less people with higher education when compared to the 
state and national average. People living in the county were less likely to have insurance 
compared to the state and the US. Men without health insurance are less likely to receive proper 
care, which increases their risk of developing and dying from prostate cancer.  
Socioeconomic indicators can play a vital role in onset of prostate cancer because men 
may not have the means to pay for proper treatment and preventative screenings. Montgomery 
County had the third highest rate of prostate cancer when compared to the other counties, Ohio, 
and the US.  
In comparison to the other metropolitan counties, Ohio, and the US in 2007, Montgomery 
County showed a slight variation with regards to the percent of men over forty who received a 
PSA test within the last two years, the percent of people who consume less than five servings of 
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fruits and vegetables, and the percent of heavy drinkers. Conversely, Montgomery County had 
the lowest rate of physical inactivity and had the highest rate of overweight people, but had the 
lowest rate of individuals who were classified as obese. Men who engage in physical activity are 
less likely to become overweight or obese and are less likely to develop prostate cancer (National 
Institutes of Health, 2009). Interventions focusing on exercise such as educational programs can 
assist on reducing the number of prostate cases in Montgomery County (American Cancer 
Society, 2012).  
Men over the age of thirty-five living in Montgomery County during the ten year time 
period were unlikely to consume more than five servings of fruits and vegetables per day. A diet 
rich in fat may be associated with an increased risk of prostate cancer (Stein & Colditz, 2004). 
Fruits can have protective or preventative effects against prostate cancer. Some fruits and 
vegetables contain anti-oxidants which serve as protective agents that shield prostate cells from 
oxidation. They also have a variety of vitamins and minerals which may protect some men from 
developing prostate cancer.  
Montgomery County was above the state and national average for the percent of men 
over the age of 40 who had a PSA test within the last two years. Since PSA testing is a screening 
tool and protective factor used to diagnose prostate cancer, above national and state average may 
possibly explain the reasoning behind why prostate cancer incidences and mortality ranks third 
and fifth respectively in Montgomery County. Furthermore, men over the age of 65 were more 
likely to receive a PSA test compared to their younger counterpart. African American men living 
in Montgomery County were slightly more likely to receive a PSA test than Caucasian men.  
Furthermore, male college graduates and men with an annual income between $25,000 
and $49,000 per year were more likely to receive a PSA examination; this may be due to their 
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overall awareness of the disease and their means to pay for treatment or receive screening for the 
disease. More than half of the men age 40 and older living in Montgomery County received a 
PSA exam within the last two years, which is above the state and national average.  
Early Detection Factors 
Secondary risk factors assessed for prostate cancer consisted of prostate cancer incidence, 
mortality, grade, and the stage of diagnosis. Additionally, data was plotted by year to examine 
the trends in prostate cancer incidence, mortality, and staging. 
Montgomery County had the second highest incidence rate for all cancer sites and the 
second lowest mortality rate for all cancer sites compared to the other counties, Ohio, and the 
US. Additionally, it had the third highest incidence rate for prostate cancer and the lowest 
mortality rate for prostate cancer. A low mortality rate may be associated with access to 
healthcare, medical insurance, and proper treatment and screenings (National Institutes of 
Health, 2008). In comparison to the other counties, Ohio, and the US, Montgomery County had 
the lowest percentage of men diagnosed with late stage prostate cancer; the reason for this may 
be due to the median annual earning for men living in the county, the number of men that receive 
PSA testing, the low percent of uninsured men, the low number of men classified as obese, and 
the percent of men that engage in physical activity.  
In Montgomery County the prostate cancer incidence rate tends to affects men beyond 
the age of 40, specifically men between the age of 60-79, which is relatively consistent globally 
(American Cancer Society, 2011). Among African American and Caucasian men the incidence 
rate peaks between the 60 to 69 age group. However, men of other or unknown races rate peaked 
between the 70 to79 age group. Beyond the age group of 60 to 69 for Caucasian and African 
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American men and 70 to 79 for men of other/unknown races, the incidence begins to decrease. 
This may be due to the amount of data collected on men beyond this age group.  
Prostate cancer by stage at diagnosis from 2003 to 2007 showed that Montgomery 
County had the highest rate of unstaged/unknown cases compared to the other counties and 
Ohio. From 2000 to 2009 Montgomery County had a large percent of cases diagnosed at the 
localized stage. However, in comparison to the other counties and Ohio from 2003 to 2007 
Montgomery County ranked last at this stage of diagnosis. In comparison to the US from 2001 to 
2007, Montgomery County was below average. Localized stage is considered an early stage 
diagnosis, and is correlated with lower mortality rates. The reason for this may be due to 
socioeconomic factors such as the percent of insured men, and the annual earning of men living 
in the county. Additionally, the number of men that receive proper testing and screenings, and 
the percent of men who are insured may explain the reasoning behind early stage diagnosis in 
Montgomery County. During that time period, there has been much variability with regional and 
distant stage of diagnosis. Despite, the large percent of localized stage of diagnosis and the 
variability in distant and regional stage at diagnosis, Montgomery County stage at diagnosis is 
lower than the national average.  
The trend for all stages of prostate cancer at diagnosis from 2000 to 2009 remained 
generally consistent for all races. However, a larger rate of Caucasian men were diagnosed with 
prostate cancer for each year during that time period compared to African American men and 
men of other or unknown races. This is because Caucasian men make up a larger portion of the 
population. Specifically, from 2007 to 2008, the rate of Caucasian men diagnosed with all stages 
of prostate cancer decreased slightly, while the rate for African American men diagnosed at all 
stages of prostate cancer increased slightly. The opposite can be seen from 2008 to 2009. The 
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rate for African American men increased, while the rate for Caucasian men decreased. This 
difference may be due to the population asymmetry between African American, and Caucasian 
men living in the county during that time period. 
When comparing prostate cancer by grade, age and race, there was not a significant 
difference between men under the age of 65 and those over the age of 65 regardless of race. 
Grade or cell differentiation describes how atypical or aggressive prostate cancer cells may 
appear. It is beneficial in predicting how a patient may respond to treatment and prognosis.  
The invasive prostate cancer trend for Montgomery County from 1998 to 2007 was 
generally consistent, maintaining an average of 147.4 cases per 100,000 people. This consistency 
is possibly due to men receiving preventative testing and screenings for early diagnosis. The 
mortality trend for Montgomery County from 2003 to 2008 increased slightly, but this is 
possibly due to misclassification of unstaged and unknown cases throughout the county.  
Descriptive Analysis of Men with Prostate Cancer in Montgomery County 
This analysis of men living in Montgomery County with prostate cancer was described 
using data from the OCISS (Ohio Department of Health, 2012). 
Men living in Montgomery County diagnosed with prostate cancer mainly included: 
Caucasian men; men in the 60 to 79 age group; men living in Dayton, Ohio and in the 45424 zip 
code; married men; and men with Medicare as their primary insurance. The result of the 
descriptive analysis is representative of population living in Montgomery County since 76 
percent of the population is Caucasian and 34 percent is age 50 and older. 
Caucasian and African American men living in the county were more likely to be 
diagnosed with late stage prostate cancer compared to men of other or unknown races who were 
more likely to be diagnosed with early stage prostate cancer. Additionally, African American and 
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Caucasian men were equally likely to be diagnosed with early or late stage diagnosis. This does 
not correspond with the literature review that African American men are less likely to be 
diagnosed with prostate cancer at a localized stage and are more likely to be diagnosed at a 
distant stage when the cancer has spread to other regions of the body (Jemal et al., 2011).  
Men in the 60 to 79 age group, and married men, were more likely to be diagnosed with 
early stage prostate cancer. This confirms the literature review that age is a strong risk factor for 
prostate cancer; men over the age of fifty are more likely to be diagnosed with prostate cancer 
(Delongchamps, Singh, & Hass, 2006). Interestingly, men living in the City of Dayton were 
more likely to be diagnosed with early stage prostate cancer; while men living in the 45424 zip 
code were more likely to be diagnosed with late stage prostate cancer. Primary payer at diagnosis 
showed that men with private insurance or on Medicare were more likely to be diagnosed with 
late stage prostate cancer. This correspond with the literature review that insurance type 
influence the type treatment received (Sadetsky et al., 2008).  
Men living in the county were more likely to survive when diagnosed with early stage 
prostate cancer compared to those diagnosed at the late stage. This corresponds with the 
literature review that there is a 100% survival rate among men of all races diagnosed with 
localized prostate cancer within for the first five years of diagnosis (Fedewa et al., 2010). 
Considering that from 2000 to 2009 a large percentage of men living in the county were 
diagnosed localized prostate cancer.  
When examining the health disparity by race, it was determined that there was a disparity 
among Caucasian men diagnosed with the disease. During the ten year time period, 70.1 percent 
of all prostate cancer cases were Caucasian men and 73.2% of all who died from prostate cancer 
were Caucasian men.  
MONTGOMERY COUNTY PROSTATE CANCER                                                               63 
Limitations 
The lack of data available from the OCISS for men of other and unknown races serves as 
a limitation to the study. Additionally, the estimated data for the percent of men who consume 
less than 5 servings of fruits or vegetables per day in Montgomery County may serve as a 
limitation of this study because the percentages can be higher or lower than the estimated 
percentages reported. The percent of men 40 and older who reported having had a prostate 
specific antigen test living in Montgomery County may also serve as a limitation of this study 
because there may be some variation with the estimated reported percentages. Lastly, the low 
number of cases available for unstaged/unknown cases may serve as a limitation of this study. 
Accurate cancer stage diagnosis is essential because treatment is directly associated to cancer 
stage. Therefore, inaccurate staging could lead to improper treatment, and may reduce a patient 
chance of survival.  
Conclusion 
Men living in Montgomery County are likely to be diagnosed with early stage prostate 
cancer. The incidence and mortality rate of prostate cancer in Montgomery County is highly 
associated with men beyond the age of 40 years old. The incidence and mortality disparity 
between African American men, Caucasian men, and men of other or unknown races is unlikely 
due to race, but more likely due to treatment, screening, diets, access to care, the quality of care 
received, and the presence of co-morbid conditions.  
This study demonstrated that disparities exist in Montgomery County with regards to 
prostate cancer incidence and mortality, race, age, survival, primary payer, city, and zip code. 
However, more data is needed to determine a causal relationship between these variables. 
Measures can be taken to reduce the risk of developing prostate cancer such as, maintaining a 
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healthy diet, increasing fruits and vegetables intake, maintaining a healthy weight, and increasing 
physical activity. Measures should be implemented to decrease prostate cancer health disparities 
through community-based participatory education, training, and research among racial/ethnic 
minorities and underserved populations in Montgomery County. 
Prostate cancer has multiple modifiable and non-modifiable risk factors ranging from 
lifestyle to hormonal factors. Understanding the diversity of prostate cancer may lead to more 
studies focusing on a personalized approach to treatment and screening. Identifying markers to 
monitor, similar to high cholesterol as a predictor for heart disease, may give some indication as 
to those at risk of developing the disease. Diet and lifestyle modification can be a daunting task, 
but markers such as these can act as an incentive for people to modify their behavior.  
Lastly, primary prevention programs can be used to educate men on the benefits of 
exercise, maintaining a healthy weight, fruit and vegetable consumptions, and receiving proper 
screening. Real progress will be achieved when future studies address the causes of prostate 
cancer and implement early treatment and screening plans to better asses and manage 
individuals, especially those who are at higher risk of developing the prostate cancer. 
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Appendix B - Independent Review Board Letter of Approval (PHDMC) 
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Appendix C – List of Public Health Competencies Met 
Domain #1: Analytic/Assessment 
Identify the health status of populations and their related determinants of health and illness (e.g., factors 
contributing to health promotion and disease prevention, the quality, availability and use of health services) 
Describe the characteristics of a population-based health problem (e.g., equity, social determinants, 
environment) 
Use variables that measure public health conditions 
Use methods and instruments for collecting valid and reliable quantitative and qualitative data 
Identify sources of public health data and information 
Recognize the integrity and comparability of data 
Identify gaps in data sources 
Adhere to ethical principles in the collection, maintenance, use, and dissemination of data and information 
Describe the public health applications of quantitative and qualitative data 
Collect quantitative and qualitative community data (e.g., risks and benefits to the community, health and 
resource needs) 
Use information technology to collect, store, and retrieve data 
Domain #2: Policy Development and Program Planning 
Gather information relevant to specific public health policy issues 
Explain the expected outcomes of policy options (e.g., health, fiscal, administrative, legal, ethical, social, 
political) 
Identify mechanisms to monitor and evaluate programs for their effectiveness and quality 
Demonstrate the use of public health informatics practices and procedures (e.g., use of information systems 
infrastructure to improve health outcomes) 
Domain #3: Communication 
Communicate in writing and orally, in person, and through electronic means, with linguistic and cultural 
proficiency 
Convey public health information using a variety of approaches (e.g., social networks, media, blogs) 
Participate in the development of demographic, statistical, programmatic and scientific presentations 
Domain #4: Cultural Competency 
Describe the dynamic forces that contribute to cultural diversity 
Domain #5: Community Dimensions of Practice 
Recognize community linkages and relationships among multiple factors (or determinants) affecting health 
(e.g., The Socio-Ecological Model) 
Identify community assets and resources 
Domain #6:Public Health Sciences 
Describes the scientific foundation of the field of public health 
Relate public health science skills to the Core Public Health Functions and Ten Essential Services of Public 
Health 
Identify the basic public health sciences (including, but not limited to biostatistics, epidemiology, environmental 
health sciences, health services administration, and social and behavioral health sciences) 
Describe the scientific evidence related to a public health issue, concern, or, intervention 
Retrieve scientific evidence from a variety of text and electronic sources 
Discuss the limitations of research findings (e.g., limitations of data sources, importance of observations and 
interrelationships) 
Domain #7: Financial Planning and Management- N/A 
Domain #8: Leadership and Systems Thinking 
Identify internal and external problems that may affect the delivery of Essential Public Health Services 
Use individual, team and organizational learning opportunities for personal and professional development 
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